Barclays’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,278	Closed	-$29.8K	–	5210
2023 Q1	$29.8K	Buy	3,278 +1,552	+90%	+$22K	﹤0.01%	4573
2022 Q4	$20.2K	Buy	1,726 +1,453	+532%	+$25.6K	﹤0.01%	4809
2022 Q3	$6K	Sell	273 -50	-15%	-$1.35K	﹤0.01%	4480
2022 Q2	$8K	Buy	+323	New	+$11K	﹤0.01%	4704
2021 Q3	–	Sell	-2,839	Closed	-$285K	–	5079
2021 Q2	$285K	Sell	2,839 -2,251	-44%	-$219K	﹤0.01%	3385
2021 Q1	$475K	Buy	5,090 +2,924	+135%	+$296K	﹤0.01%	3206
2020 Q4	$179K	Buy	+2,166	New	+$185K	﹤0.01%	3824
2020 Q1	–	Sell	-2	Closed	–	–	6572
2019 Q4	$0	Sell	2 -1,377	-100%	-$30.2K	﹤0.01%	6935
2019 Q3	$19K	Buy	+1,379	New	+$28.9K	﹤0.01%	6227
2018 Q2	–	Sell	-223	Closed	-$23K	–	7383
2018 Q1	$23K	Sell	223 -545	-71%	-$65K	﹤0.01%	6378
2017 Q4	$98K	Buy	768 +751	+4,418%	+$92.3K	﹤0.01%	5264
2017 Q3	$2K	Sell	17 -174	-91%	-$20.9K	﹤0.01%	6701
2017 Q2	$25K	Buy	+191	New	+$25.8K	﹤0.01%	5690